Multi-institutional, randomized, double-blind, placebo-controlled trial to assess the efficacy of a mucoadhesive hydrogel (MuGard) in mitigating oral mucositis symptoms in patients being treated with chemoradiation therapy for cancers of the head and neck.

RR, Allison; AA, Ambrad; Y, Arshoun; RJ, Carmel; DF, Ciuba; E, Feldman; SE, Finkelstein; R, Gandhavadi; DE, Heron; SC, Lane; JM, Longo; C, Meakin; D, Papadopoulos; DE, Pruitt; LM, Steinbrenner; MA, Taylor; WM, Wisbeck; GE, Yuh; DP, Nowotnik; ST, Sonis

doi:10.1002/cncr.28553

Public

Multi-institutional, randomized, double-blind, placebo-controlled trial to assess the efficacy of a mucoadhesive hydrogel (MuGard) in mitigating oral mucositis symptoms in patients being treated with chemoradiation therapy for cancers of the head and neck.

Shared by NobleBlocks on May 1, 2014 • 12:00 AM UTC

Authors:

Allison RR

Ambrad AA

Arshoun Y

Abstract

Background The objective of this trial was to determine how a mucoadhesive hydrogel (MuGard), a marketed medical device, would fare when tested with the strictness of a conventional multi-institutional, double-blind, randomized, placebo-controlled study format.Methods A total of 120 subjects planned...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!